Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.

No abstract available.

Abraham JM, Agarwal R, Beer DG, Cheng Y, David S, Hamilton JP, Ito T, Jin Z, Kan T, Meltzer SJ, Mori Y, Olaru A, Paun B, Sato F, Selaru FM, Shimada Y, Yang J

18729198

Int. J. Cancer, 2008, 123 (10)